 |
The following information is NOT intended to endorse drugs or recommend therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.
Learn more about Depen Titratabs.
No reviews have yet been submitted. Be the first to review this drug.
Pregnancy Category Positive evidence of risk
More than 40 percent of rheumatoid arthritis patients live a sedentary life, a new study finds. It used to be thought that medication and rest was the best...
Further demonstration of the excellent safety profile of the TNF-Kinoid Identification of 2 doses and an administration schedule that are...
Dec 20, 2011 - Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA)...
GHENT, Belgium, 30 November 2011 - Ablynx [Euronext Brussels: ABLX] today announced positive Phase I data from the single ascending dose part of the Phase...
Statistically significant improvement already seen in four weeks: 83% of patients showed improvement in ACR20 score o half of treated patients went into...
Looking for answers? Ask a question or go join the Depen Titratabs support group to connect with others who have similar interests.
Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines & natural products. This material is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Data sources include Micromedex™ (updated Jan 27th, 2011), Cerner Multum™ (updated Jan 3rd, 2012), Wolters Kluwer™ (updated Jan 31st, 2012) and others.
To view content sources and attributions, refer to our editorial policy.
Copyright © 2000-2012 Drugs.com. All rights reserved.
We comply with the HONcode standard for trustworthy health information.
Verify here
